Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Mark Eckardt, M.D.

Concepts (171)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Mark Eckardt's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Mark Eckardt has written about over time.
Hemangioendothelioma, Epithelioid, 1 publications between 2011 and 2011, average publication date July 2011. Blast Crisis, 1 publications between 2011 and 2011, average publication date October 2011. Chromosomes, Human, Pair 1, 1 publications between 2011 and 2011, average publication date October 2011. Chromosomes, Human, Pair 19, 1 publications between 2011 and 2011, average publication date October 2011. Leukemia, Myelogenous, Chronic, BCR-ABL Positive, 1 publications between 2011 and 2011, average publication date October 2011. Philadelphia Chromosome, 1 publications between 2011 and 2011, average publication date October 2011. Compartment Syndromes, 1 publications between 2013 and 2013, average publication date February 2013. Radiodermatitis, 1 publications between 2013 and 2013, average publication date February 2013. Deoxycytidine, 2 publications between 2013 and 2018, average publication date July 2015. Antimetabolites, Antineoplastic, 2 publications between 2013 and 2018, average publication date November 2015. Xenograft Model Antitumor Assays, 9 publications between 2016 and 2018, average publication date November 2017. Doxorubicin, 9 publications between 2016 and 2018, average publication date February 2018. Carbon-Sulfur Lyases, 6 publications between 2018 and 2018, average publication date April 2018. Salmonella typhimurium, 5 publications between 2018 and 2018, average publication date June 2018. Sarcoma, 8 publications between 2016 and 2021, average publication date December 2018. Nerve Sheath Neoplasms, 2 publications between 2019 and 2019, average publication date July 2019. Liposarcoma, 4 publications between 2018 and 2023, average publication date November 2020. Retroperitoneal Neoplasms, 1 publications between 2022 and 2022, average publication date December 2022.

To see the data from this visualization as text, click here.
Eckardt's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (171)
Explore
_
Co-Authors (1)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.